Quick Takeaways
- Alessandra Cesano has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $169,106.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Alessandra Cesano and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY, INC. | Director | $140,908 | -$132,219 | -48% | 18 Jul 2025 |
| SMMT | Summit Therapeutics Inc. | Director | $28,198 | 02 Jan 2026 | ||
| EPIX | ESSA Pharma Inc. | Chief Medical Officer | 25 Mar 2024 | |||
| ZYME | Zymeworks Inc. | Director | 12 Jan 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|